LDLR and atherosclerosis: In particular, two mouse models, the apolipoprotein (Apo) E-deficient mice and the low-density lipoprotein receptor (LDLr)-deficient mice [5], [6], have been particularly useful in advancing our understanding of the molecular basis of atherosclerosis and the roles of various cytokines in the disease [2], [3], [4].